WOMENS HEALTH

Therapeutics for Ladies’s Well being – A Complete Business Evaluation Highlighting the Key Alternatives, Pricing & Reimbursement, Gamers, and Strategic Suggestions

DUBLIN, March 11, 2022 /PRNewswire/ — The “Therapeutics for Ladies’s Well being: Applied sciences and World Markets” report has been added to ResearchAndMarkets.com’s providing.

This report is an analytical enterprise software that comprehensively evaluates the worldwide marketplace for girls’s well being therapeutics. The format of the examine is organized across the following matters:

  • Detailed examine round girls’s illnesses, comparable to endometriosis, postmenopausal osteoporosis, menopause, breast most cancers and PCOS
  • Illness incidence and prevalence
  • Regulatory construction of pharmaceutical trade
  • Market characterization, unmet want, market measurement and segmentation
  • Market drivers and restraints
  • Detailed market projections via 2026
  • Competitors and market shares
  • Pricing and reimbursement
  • Marketed and pipeline (R&D) merchandise together with description, regulatory standing, and scientific trials
  • Observations and conclusions relating to the way forward for marketplace for girls’s well being therapeutics
  • Profiles of market members and associations

The report consists of:

  • 58 information tables and 56 extra tables
  • An summary of the worldwide market and applied sciences for girls’s well being therapeutics
  • Estimation of the market measurement and analyses of world market traits, with information from 2018, 2019, 2020, estimates for 2021 and projections of compound annual development charges (CAGRs) via 2026
  • Detailed examine round girls’s illnesses comparable to endometriosis, postmenopausal osteoporosis, menopause, breast most cancers and polycystic ovary syndrome (PCOS); their historic background, phases, signs, threat elements and genetic elements, prognosis, and remedy, etiology, pathophysiology, epidemiology, and financial burden
  • Dialogue on growing older and girls’s well being problems, girls & sexual well being comparable to feminine sexual arousal dysfunction, feminine orgasmic dysfunction, and vaginismus and relation between infertility and most cancers
  • Protection of regulatory construction, pricing, and reimbursement eventualities; marketed and pipeline (R&D) merchandise, and scientific trials
  • Identification of market drivers, restraints and different forces impacting the worldwide market and analysis of present market measurement and forecast
  • Market share evaluation of the important thing firms of the trade and protection of their proprietary applied sciences, strategic alliances, and different key market methods
  • Complete firm profiles of the main gamers of the trade, together with Roche, Eli Lilly, Pfizer, AstraZeneca, Novartis, Amgen, and Merck

Key Matters Lined

Chapter 1 Introduction

  • Examine Objectives and Goals
  • What’s New on this Replace?
  • Causes for Doing This Examine
  • Scope of Report
  • Data Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials

Chapter 2 Abstract and Highlights

Chapter 3 Overview of Applied sciences and World Markets

  • Illness Overview and Definitions
  • Historic Background
  • Market Driving Components and Alternatives
    • Growing old Feminine Inhabitants
    • Authorities Involvement and Elevated Funding
    • Rising Consciousness Concerning Ladies’s Issues and Remedies
  • Market Restraints
    • Poor Analysis
    • Availability of Alternate Therapy Choices and Life-style Adjustments
    • Unavailability of Novel Remedies
    • Excessive Therapy Value of Osteoporosis
  • Alternatives
    • Rising Feminine Inhabitants in Asia-Pacific
    • Elevated Demand for Expertise Innovation
    • Mergers and Acquisitions

Chapter 4 Affect of COVID-19 Pandemic

  • Implications on Ladies’s Well being and Analysis
  • Implications on Most cancers Therapy
  • Affect on Oncology Prescribed drugs Market

Chapter 5 Pipeline Evaluation and Evaluation

  • Ladies’s Well being Therapeutics: Key Scientific Trial Developments
  • Checklist of Medicine in Pipeline
  • Overview of Osteoporosis Drug Improvement Pipeline
  • Late-stage Pipeline Medicine

Chapter 6 Regulatory Construction

  • Overview of Rules
  • U.S.
  • Canada
  • Europe
  • Japan

Chapter 7 Market Breakdown by Ladies’s Well being Dysfunction

  • Introduction
  • Menopause-Associated Illnesses
    • Overview
    • Signs
    • Threat Components
    • Epidemiology and Financial Burden
    • Analysis
    • Remedies
    • Market Dimension and Forecast
  • Postmenopausal Osteoporosis
    • Overview
    • Epidemiology and Financial Burden
    • Analysis
    • Remedies
    • Market Dimension and Forecasts
  • Endometriosis
    • Overview
    • Epidemiology and Financial Burden
    • Analysis
    • Remedies
    • Market Dimension and Forecasts
  • Polycystic Ovary Syndrome
    • Overview
    • Etiology
    • Decreasing PCOS Threat
    • Epidemiology and Financial Burden
    • Illness Signs and Threat Components
    • Analysis
    • Remedies
    • Market Dimension and Forecasts
  • Breast Most cancers
    • Overview
    • Market Dimension and Forecasts

Chapter 8 Market Breakdown by Area

  • Introduction
  • North America
  • Europe
    • U.Ok.
    • Germany
    • France
    • Spain
    • Italy
    • Remainder of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Remainder of Asia-Pacific
  • Remainder of the World
    • South America
    • Center East and Africa

Chapter 9 Pricing and Reimbursement

  • Overview of Pricing and Reimbursement
  • U.S.
  • Canada
  • Europe
  • Japan

Chapter 10 Aggressive Panorama and Key Developments

  • Market Gamers and Methods
  • Blockbuster Breast Most cancers Pharmaceutical Manufacturers
  • Patent Evaluation
  • Checklist of Key Patents
  • Key Developments
  • Mergers and Acquisitions
  • Improvement of Progressive Merchandise/Novel Product Launch
  • Agreements, Collaborations and Partnerships
  • Key Merchandise

Chapter 11 Firm Profiles

  • Abbvie Inc.
  • Amgen Inc.
  • Asahi Kasei
  • Astrazeneca plc
  • Bayer AG
  • Bristol-Myers Squibb
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • Eisai
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • Johnson & Johnson Companies Inc.
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.

Chapter 12 Conclusions: Outlook for Ladies’s Well being Therapeutics

  • Main Developments to Affect Market
  • Therapeutic Developments
  • Demographic and Financial Developments
  • Revenue Progress in Rising Markets
  • Future Outlook

Chapter 13 Appendix A: Glossary of Phrases

Chapter 14 Appendix B: Business and Skilled Organizations

For extra details about this report go to https://www.researchandmarkets.com/r/i2qhkt

Media Contact:

Analysis and Markets
Laura Wooden, Senior Supervisor
[email protected]

For E.S.T Workplace Hours Name +1-917-300-0470
For U.S./CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outdoors U.S.): +353-1-481-1716

SOURCE Analysis and Markets

Related Articles

Back to top button